PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have ongoing musculoskeletal pain (such as pain in muscles, joints, or bones) that is not related to cancer, has lasted at least six months, rates 3 or higher on a 0–10 pain scale, and significantly interferes with daily life, with a confirmed diagnosis recorded in their medical records.
- People who have been diagnosed with PTSD (Post-Traumatic Stress Disorder), confirmed through a structured clinical interview and a standardised questionnaire score of 30 or above.
- People who are willing to take part in all parts of the study, including being randomly assigned to a treatment group and completing all assessments.
Who may not be able to join:
- People who live in the same household as someone already enrolled in this trial.
- People who are currently experiencing active psychosis (a break from reality) or dementia, as assessed at the screening stage.
- People who are currently having thoughts of suicide with a clear intention to act on them.
- People who currently have a dependence on alcohol or other substances.
- People who are currently taking opioid medications for pain, or who are currently using certain other medications — including sodium channel blockers, calcium channel blockers, or NMDA receptor antagonists — as these can interfere with the trial treatment (confirm with trial site if unsure whether a current medication falls into these categories).
- People who are currently pregnant or breastfeeding.
- People who are currently enrolled in another clinical trial for pain.
- People who have certain medical conditions or circumstances that are not compatible with the trial's brain stimulation treatment (called tDCS), including: a penetrating traumatic brain injury, a seizure disorder, pregnancy, metal implants inside the body, or claustrophobia (fear of enclosed spaces).
- People whose pain is not considered chronic, or who have severe and frequent migraines, fibromyalgia, or pain that is primarily caused by another condition such as cancer.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Melba Hernandez-Tejada, PhD, DHA, The University of Texas Health Science Center, Houston
Phone: 713 4862729
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in pain intensity as measured by the Defense and Veterans Pain Rating Scale (DVPRS); Change in PTSD symptoms as assessed by the Clinician-Administered PTSD Scale 5 (CAPS-5)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.